Apnimed’s $25 Million Series B Financing

Troutman Pepper Hamilton Sanders LLP advised Apnimed on the deal.Apnimed, a clinical-stage company focused on advancing pharmacologic treatments for sleep apnea and related disorders, has raised…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Martina Bellini

Author: Martina Bellini

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here